114 related articles for article (PubMed ID: 18335652)
21. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
22. Long-term benefits of darifenacin treatment for patient quality of life: results from a 2-year extension study.
Dwyer P; Kelleher C; Young J; Haab F; Lheritier K; Ariely R; Ebinger U
Neurourol Urodyn; 2008; 27(6):540-7. PubMed ID: 18663723
[TBL] [Abstract][Full Text] [Related]
23. Effect of skin care with an emollient containing a high water content on mild uremic pruritus.
Okada K; Matsumoto K
Ther Apher Dial; 2004 Oct; 8(5):419-22. PubMed ID: 15663539
[TBL] [Abstract][Full Text] [Related]
24. Type of soap and the incidence of skin tears among residents of a long-term care facility.
Mason SR
Ostomy Wound Manage; 1997 Sep; 43(8):26-30. PubMed ID: 9385176
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
[TBL] [Abstract][Full Text] [Related]
26. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
27. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea.
Wu JJ; Weinstein GD; Kricorian GJ; Kormeili T; McCullough JL
Clin Exp Dermatol; 2007 Nov; 32(6):693-5. PubMed ID: 17868391
[TBL] [Abstract][Full Text] [Related]
28. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
Dinsmore WW; Wyllie MG
BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
[TBL] [Abstract][Full Text] [Related]
29. New cosmetic emulsions for dry skin.
Machado M; Bronze MR; Ribeiro H
J Cosmet Dermatol; 2007 Dec; 6(4):239-42. PubMed ID: 18047608
[TBL] [Abstract][Full Text] [Related]
30. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
31. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
32. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
Chokka P; Legault M
Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
[TBL] [Abstract][Full Text] [Related]
34. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
[TBL] [Abstract][Full Text] [Related]
35. The role of emollients in the management of diseases with chronic dry skin.
Proksch E
Skin Pharmacol Physiol; 2008; 21(2):75-80. PubMed ID: 18187966
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
[TBL] [Abstract][Full Text] [Related]
37. Topical antioxidant application enhances the effects of facial microdermabrasion.
Freedman BM
J Dermatolog Treat; 2009; 20(2):82-7. PubMed ID: 18720185
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study.
Hamza MS; Anderson DG; Snyder JW; Deschner S; Cifu DX
PM R; 2009 Apr; 1(4):335-9. PubMed ID: 19627916
[TBL] [Abstract][Full Text] [Related]
40. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
